Common Stock, Shares, Outstanding of Alaunos Therapeutics, Inc. from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Alaunos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • Alaunos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 2,205,846, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Alaunos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,205,846 +604,594 +38% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 2,074,746 +473,494 +30% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,601,252 -14,411,270 -90% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,601,252 0 0% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,601,252 -239,025,803 -99% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 1,601,252 -239,025,803 -99% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 16,012,522 -224,614,533 -93% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 1,601,252 -14,426,132 -90% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 240,627,055 +24,445,013 +11% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 240,627,055 +24,452,513 +11% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 240,627,055 +24,676,494 +11% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 16,027,384 -200,100,059 -93% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 216,182,042 +36,238 +0.02% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 216,174,542 +615,394 +0.28% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 215,950,561 +692,887 +0.32% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 216,127,443 +1,535,537 +0.72% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 216,145,804 +1,980,114 +0.92% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 215,559,148 +1,266,978 +0.59% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 215,257,674 +971,337 +0.45% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 214,591,906 +32,788,586 +18% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 214,165,690 +33,135,670 +18% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 214,292,170 +51,814,207 +32% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 214,286,337 +51,999,176 +32% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 181,803,320 +20,737,184 +13% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 181,030,020 +38,650,250 +27% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 162,477,963 +20,098,193 +14% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 162,287,161 +19,888,225 +14% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 161,066,136 +18,408,099 +13% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 142,379,770 +416,981 +0.29% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 142,379,770 +416,981 +0.29% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 142,398,936 +10,017,266 +7.6% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 142,658,037 +10,281,367 +7.8% 31 Dec 2017 10-K 05 Mar 2019 2018 FY
Q3 2017 141,962,789 +10,230,366 +7.8% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 141,962,789 +10,230,366 +7.8% 30 Jun 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 132,381,670 +578,797 +0.44% 31 Mar 2017 10-Q 01 May 2017 2017 Q1
Q4 2016 132,376,670 +658,091 +0.5% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 131,732,423 +844,522 +0.64% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 131,732,423 +910,389 +0.7% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 131,802,873 +3,570,336 +2.8% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 131,718,579 +27,266,474 +26% 31 Dec 2015 10-K 16 Feb 2017 2016 FY
Q3 2015 130,887,901 +28,203,917 +27% 30 Sep 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 130,822,034 +30,096,968 +30% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 128,232,537 +27,631,871 +27% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 104,452,105 +4,292,487 +4.3% 31 Dec 2014 10-K 24 Feb 2016 2015 FY
Q3 2014 102,683,984 +19,002,405 +23% 30 Sep 2014 10-Q 30 Oct 2014 2014 Q3
Q2 2014 100,725,066 +17,184,384 +21% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 100,600,666 +16,919,817 +20% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 100,159,618 +16,922,778 +20% 31 Dec 2013 10-K 26 Feb 2015 2014 FY
Q3 2013 83,681,579 +4,061,982 +5.1% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 83,540,682 +3,915,392 +4.9% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 83,680,849 +4,147,967 +5.2% 31 Mar 2013 10-Q 07 May 2013 2013 Q1
Q4 2012 83,236,840 +14,030,796 +20% 31 Dec 2012 10-K 03 Mar 2014 2013 FY
Q3 2012 79,619,597 +11,168,273 +16% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 79,625,290 +11,313,063 +17% 30 Jun 2012 10-Q/A 28 Aug 2012 2012 Q2
Q1 2012 79,532,882 31 Mar 2012 10-Q 03 May 2012 2012 Q1
Q4 2011 69,206,044 +20,739,482 +43% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 68,451,324 +19,893,646 +41% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 68,312,227 30 Jun 2011 10-Q/A 09 Aug 2011 2011 Q2
Q4 2010 48,466,562 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 48,557,678 30 Sep 2010 10-Q 01 Aug 2011 2010 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.